Impact Factor
3.31
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.72
503 total citations
h5-index
27
h5 depth signal
Cited share
70.2%
139 of 198
Total citations
503
Citation footprint
Metric signal
2.37
External metric anchor
Self-citation
8.7%
44 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Greece
410
China
123
Turkey
87
Italy
81
United States
66
Citing Fields of Research
Endocrinology & Metabolism
399
Diabetes
223
Adrenal Dysfunction
99
Osteopathies
81
Endocrine Therapy
75
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,568
Articles tracked across the journal lifetime
Indexed publication set
198
139 cited publications
Last 12 months
106
8.8 publications/month
Open access share
28.3%
30 OA publications in the last year
Leading citing country
Greece
410 citing publications
Leading citing field
Endocrinology & Metabolism
399 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan.-Mar. 2005-
v4n1, Jan.-Mar. 2005-
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Diabetes
Adrenal Dysfunction
Endocrine Therapy
Human Reproduction
Issuing & Sponsoring Bodies
Contributor
Hellenikē Endokrinologikē Hetaireia
Broad Categories
Endocrinology
Endocrinology & Metabolism
Diabetes
Endocrine Therapy
Osteopathies
Human Reproduction
MeSH Descriptors
Endocrine Glands
Endocrine System Diseases
Hormones
Metabolic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s42000-026-00832-w
Open DOI
Machine learning and penalized logistic regression-based models for the identification of potential characteristic genes in primary hyperparathyroidism
Purpose: Primary hyperparathyroidism (PHPT) is an endocrine disorder in which one or more parathyroid glands oversecrete parathyroid hormone, leading to hypercalcemia and potential complications such as kidney stones, bone fractures, and...
02
DOI 10.1007/s42000-026-00780-5
Open DOI
Antidiabetic medications in the pipeline
03
DOI 10.1007/s42000-026-00831-x
Open DOI
Effects of calcitriol (1,25(OH)₂D₃) on endothelial-derived factors implicated in atheromatous plaque vulnerability
Background: Atherosclerosis progresses from endothelial dysfunction to arterial plaque vulnerability, rupture, erosion, and calcification. Vitamin D deficiency is an independent cardiovascular risk factor associated with advanced atheros...
04
05
DOI 10.1007/s42000-026-00833-9
Open DOI
Weekday–weekend sleep patterning and testosterone outcomes in US men: a cross-sectional analysis of NHANES 2011–2014
Purpose Weekday-weekend differences in sleep duration are common, but their associations with testosterone and the specificity of corrected weekend catch-up sleep (CUS) as a sleep-pattern measure remain uncertain. We examined corrected C...
06
07
DOI 10.1007/s42000-026-00830-y
Open DOI
Beyond insulin resistance: insights into the clinical utility of TyG and TG/HDL-C in hospitalized patients
Background The triglyceride-glucose (TyG) index and triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio are established surrogate markers of insulin resistance and cardiometabolic risk, but their interpretation in hospi...
08
DOI 10.1007/s42000-026-00829-5
Open DOI
Epigenetic modifications in type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) develops through the interplay of insulin resistance and progressive beta-cell dysfunction. Beyond genetic predisposition, epigenetic regulation provides a mechanistic link between environmental exposures ...
09
DOI 10.1007/s42000-026-00822-y
Open DOI
Hormonal target validation based on biochemical shifts in gender-affirming hormone therapy
Background Hormonal targets for gender-affirming hormone therapy (GAHT) remain largely unvalidated in gender-diverse individuals, with no clinical markers to assess dosing adequacy. We hypothesize that a biochemical shift towards the hor...
10
DOI 10.1007/s42000-026-00827-7
Open DOI
Glucagon-like peptide-1 receptor agonists and cognitive function: beyond the metabolic effects
Bibliographical & Catalog Notes
Title from cover.
Also issued online.